DK3952858T3 - Fremgangsmåde til behandling af tumorer - Google Patents

Fremgangsmåde til behandling af tumorer

Info

Publication number
DK3952858T3
DK3952858T3 DK20787143.5T DK20787143T DK3952858T3 DK 3952858 T3 DK3952858 T3 DK 3952858T3 DK 20787143 T DK20787143 T DK 20787143T DK 3952858 T3 DK3952858 T3 DK 3952858T3
Authority
DK
Denmark
Prior art keywords
treating tumors
tumors
treating
Prior art date
Application number
DK20787143.5T
Other languages
Danish (da)
English (en)
Inventor
Victoria Anne Gordon
Paul Warren Reddell
Glen Mathew Boyle
Jason Kingsley Cullen
Peter Gordon Parsons
Original Assignee
QBiotics Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2019901280A external-priority patent/AU2019901280A0/en
Application filed by QBiotics Pty Ltd filed Critical QBiotics Pty Ltd
Application granted granted Critical
Publication of DK3952858T3 publication Critical patent/DK3952858T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK20787143.5T 2019-04-12 2020-04-09 Fremgangsmåde til behandling af tumorer DK3952858T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2019901280A AU2019901280A0 (en) 2019-04-12 Method of Treatment
PCT/AU2020/050360 WO2020206504A1 (en) 2019-04-12 2020-04-09 Method of treating tumours

Publications (1)

Publication Number Publication Date
DK3952858T3 true DK3952858T3 (da) 2026-02-23

Family

ID=72752169

Family Applications (1)

Application Number Title Priority Date Filing Date
DK20787143.5T DK3952858T3 (da) 2019-04-12 2020-04-09 Fremgangsmåde til behandling af tumorer

Country Status (26)

Country Link
US (1) US12226391B2 (https=)
EP (1) EP3952858B1 (https=)
JP (2) JP2022528915A (https=)
KR (1) KR20210152531A (https=)
CN (1) CN113924091A (https=)
AU (1) AU2020256847B2 (https=)
BR (1) BR112021020253A2 (https=)
CA (1) CA3136216C (https=)
DK (1) DK3952858T3 (https=)
EA (1) EA202192757A1 (https=)
ES (1) ES3063750T3 (https=)
FI (1) FI3952858T3 (https=)
HR (1) HRP20260232T1 (https=)
IL (1) IL287210B2 (https=)
LT (1) LT3952858T (https=)
MX (1) MX2021012449A (https=)
MY (1) MY208979A (https=)
PL (1) PL3952858T3 (https=)
PT (1) PT3952858T (https=)
RS (1) RS67777B1 (https=)
SG (1) SG11202110599RA (https=)
SI (1) SI3952858T1 (https=)
SM (1) SMT202600066T1 (https=)
UA (1) UA129840C2 (https=)
WO (1) WO2020206504A1 (https=)
ZA (1) ZA202108677B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ597019A (en) * 2005-12-23 2013-11-29 Qbiotics Ltd Tiglien-3-one derivatives
JP7013753B2 (ja) * 2017-09-15 2022-02-01 株式会社三洋物産 遊技機
IL289072B2 (en) 2019-06-19 2025-06-01 QBiotics Pty Ltd Biofilm disruption
JP2024546296A (ja) * 2021-12-21 2024-12-19 キューバイオティクス プロプライアタリー リミティド 結晶性中間体
CN120569368A (zh) * 2022-12-21 2025-08-29 Q生物股份有限公司 晶型及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ597019A (en) * 2005-12-23 2013-11-29 Qbiotics Ltd Tiglien-3-one derivatives
UA118670C2 (uk) * 2013-04-18 2019-02-25 К'Юбайотікс Лімітед Способи та композиції для загоєння ран
JP2019523303A (ja) * 2016-07-28 2019-08-22 キューバイオティクス リミティド 治療方法
CN110461324A (zh) 2017-03-23 2019-11-15 Q生物股份有限公司 用于治疗或预防肿瘤的联合疗法

Also Published As

Publication number Publication date
LT3952858T (lt) 2026-04-10
US20220193023A1 (en) 2022-06-23
IL287210B2 (en) 2025-07-01
AU2020256847A1 (en) 2021-11-11
PT3952858T (pt) 2026-02-26
IL287210B1 (en) 2025-03-01
SG11202110599RA (en) 2021-10-28
CA3136216A1 (en) 2020-10-15
CN113924091A (zh) 2022-01-11
EP3952858A1 (en) 2022-02-16
EP3952858B1 (en) 2025-12-17
ES3063750T3 (en) 2026-04-20
WO2020206504A1 (en) 2020-10-15
SMT202600066T1 (it) 2026-03-09
JP2022528915A (ja) 2022-06-16
ZA202108677B (en) 2026-03-25
AU2020256847B2 (en) 2025-05-15
IL287210A (en) 2021-12-01
US12226391B2 (en) 2025-02-18
RS67777B1 (sr) 2026-03-31
JP2025060945A (ja) 2025-04-10
MY208979A (en) 2025-06-14
HRP20260232T1 (hr) 2026-03-27
PL3952858T3 (pl) 2026-03-30
EA202192757A1 (ru) 2022-02-11
FI3952858T3 (fi) 2026-02-18
MX2021012449A (es) 2021-11-12
CA3136216C (en) 2024-01-16
EP3952858A4 (en) 2022-05-25
KR20210152531A (ko) 2021-12-15
UA129840C2 (uk) 2025-08-20
BR112021020253A2 (pt) 2021-12-07
SI3952858T1 (sl) 2026-04-30

Similar Documents

Publication Publication Date Title
IL285496A (en) Methods for treating cholestasis
DK3559265T3 (da) Fremgangsmåde til behandling af polynukleotider
DK3986897T3 (da) EGFR-hæmmer til cancerbehandling
IL290454A (en) Method of treating kras-associated cancers
DK3478286T3 (da) Fremgangsmåder til behandling af ovariecancer
DK3286311T3 (da) Fremgangsmåde til behandling af maligniteter
DK3322722T3 (da) Midler, anvendelser og fremgangsmåder til behandling af synukleinopati
IL285110A (en) Methods of treating multiple myeloma
DK3952858T3 (da) Fremgangsmåde til behandling af tumorer
DK3580211T3 (da) 2-heteroaryl-3-oxo-2,3-dihydropyridazin-4-carboxamider til behandling af cancer
DK3793588T3 (da) Fremgangsmåder til behandling af hæmofili a
DK4206308T3 (da) Fremgangsmåde til behandling af lipidmaterialer
DK4034122T3 (da) Fremgangsmåder til behandling af hyperfenylalaninæmi
IL286040A (en) Methods of treating al amyloidosis
DK3661562T3 (da) Fremgangsmåde til konjugation af cys-mabs
DK3742950T3 (da) Apparat til behandling af gulve
DK4103178T3 (da) Fremgangsmåder til behandling af fabrys sygdom
DK3641777T3 (da) Fremgangsmåde til forbedring af kødkvalitet
DK3661510T3 (da) Fremgangsmåder til behandling af adfærdsændringer
DK3471722T3 (da) Forbindelser, sammensætninger og fremgangsmåder til forebyggelse og/eller behandling af cancer
DK3478284T3 (da) Forbindelser og sammensætninger til behandling af cancer
IL287130A (en) Methods of treating pruritus
IL281343A (en) Methods for treating pancreatitis
IL286857A (en) Methods for the treatment of beta-thalassemia
DK3673084T3 (da) Fremgangsmåde til indføring af mutationer